corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8691

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Sheridan C.
European pharma consolidation generates quality spinoffs.
Nat Biotechnol 2006 Dec; 24:(12):1458-9
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1458.html


Abstract:

Although Bayer Healthcare, headquartered in Leverkusen, Germany, spent most of 2006 in the spotlight because of its 16.3 billion ($19.6 billion) acquisition of Berlin-based Schering, its ongoing restructuring is bound to yield a total of three new German spin-offs to the ranks of Europe’s independent life sciences companies.

Keywords:
Publication Types: News MeSH Terms: Commerce/economics Drug Industry/economics Drug Industry/organization & administration* Europe Investments/economics


Notes:

Free full text

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend